Upon loss of epigenetic silencing in FSHD, abnormal DUX4-fl expression in adult skeletal muscle has pathological consequences by aberrantly activating target genes and DUX4-regulated cellular pathways [31]. The gene discussed is DUX4; the disease is facioscapulohumeral muscular dystrophy.